|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/33 | |
| A61K 31/34 | |||
| C07C 15/14 |
| (11) | Patento numeris | 3102198 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15745823.3 |
| Europos patento paraiškos padavimo data | 2015-02-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-12-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/014153 |
| Data | 2015-02-03 |
| (87) | Numeris | WO 2015/119899 |
| Data | 2015-08-13 |
| (30) | Numeris | Data | Šalis |
| 201461936597 P | 2014-02-06 | US |
| (72) |
CHOBANIAN, Harry, US
DEMONG, Duane, US
GUO, Yan, US
HU, Zhiyong, US
MILLER, Michael, US
PIO, Barbara, US
PLUMMER, Christopher, W., US
XIAO, Dong, US
YANG, Cangming, US
ZHANG, Rui, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | ANTIDIABETIC COMPOUNDS |
| ANTIDIABETIC COMPOUNDS |